First Time Loading...

Suzuken Co Ltd
TSE:9987

Watchlist Manager
Suzuken Co Ltd Logo
Suzuken Co Ltd
TSE:9987
Watchlist
Price: 5 184 JPY -0.23% Market Closed
Updated: Jul 12, 2024
Have any thoughts about
Suzuken Co Ltd?
Write Note

Intrinsic Value

Suzuken Co., Ltd. engages in the pharmaceutical business. [ Read More ]

The intrinsic value of one Suzuken Co Ltd stock under the Base Case scenario is 14 934.53 JPY. Compared to the current market price of 5 184 JPY, Suzuken Co Ltd is Undervalued by 65%.

Key Points:
Intrinsic Value
Base Case
14 934.53 JPY
Undervaluation 65%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Suzuken Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Suzuken Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Suzuken Co Ltd

Current Assets 948.3B
Cash & Short-Term Investments 242.1B
Receivables 557.9B
Other Current Assets 148.3B
Non-Current Assets 280.4B
Long-Term Investments 100.7B
PP&E 128.7B
Intangibles 11.2B
Other Non-Current Assets 39.8B
Current Liabilities 784.4B
Accounts Payable 744.2B
Accrued Liabilities 8.9B
Other Current Liabilities 31.3B
Non-Current Liabilities 28B
Other Non-Current Liabilities 28B
Efficiency

Earnings Waterfall
Suzuken Co Ltd

Revenue
2.4T JPY
Cost of Revenue
-2.2T JPY
Gross Profit
185.2B JPY
Operating Expenses
-150.4B JPY
Operating Income
34.9B JPY
Other Expenses
-5.9B JPY
Net Income
29B JPY

Free Cash Flow Analysis
Suzuken Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Suzuken Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Positive 3-Years Revenue Growth
Positive Free Cash Flow
46/100
Profitability
Score

Suzuken Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Suzuken Co Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
Short-Term Solvency
71/100
Solvency
Score

Suzuken Co Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Suzuken Co Ltd

Wall Street analysts forecast Suzuken Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Suzuken Co Ltd is 5 053.08 JPY with a low forecast of 4 545 JPY and a high forecast of 5 638.5 JPY.

Lowest
Price Target
4 545 JPY
12% Downside
Average
Price Target
5 053.08 JPY
3% Downside
Highest
Price Target
5 638.5 JPY
9% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Suzuken Co Ltd

1M 1M
+12%
6M 6M
+8%
1Y 1Y
+35%
3Y 3Y
+61%
5Y 5Y
-13%
10Y 10Y
+80%
Annual Price Range
5 184
52w Low
3 827
52w High
5 235
Price Metrics
Average Annual Return -12.15%
Standard Deviation of Annual Returns 14.83%
Max Drawdown -52%
Shares Statistics
Market Capitalization 402.5B JPY
Shares Outstanding 73 367 337
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Suzuken Co Ltd Logo
Suzuken Co Ltd

Country

Japan

Industry

Health Care

Market Cap

402.5B JPY

Dividend Yield

1.92%

Description

Suzuken Co., Ltd. engages in the pharmaceutical business. The company is headquartered in Nagoya, Aichi-Ken and currently employs 15,041 full-time employees. The firm operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.

Contact

AICHI-KEN
Nagoya
8, Higashi Kataha-machi, Higashi-ku
+81529612331.0
https://www.suzuken.co.jp/

IPO

1994-08-01

Employees

15 041

Officers

Chairman & Executive Officer
Mr. Hiromi Miyata
President, CEO & Director
Mr. Shigeru Asano
Executive MD, Senior GM of Healthcare Distribution Business Headquarters & Director
Mr. Hirofumi Tanaka
SeniorExec. Offr, Sen GM of Healthcaresolutions BusiHeadquarters,GM Solu Busi Plan. Dept & Director
Ms. Chie Takahashi
Director
Mr. Hisashi Tamura

See Also

Discover More
What is the Intrinsic Value of one Suzuken Co Ltd stock?

The intrinsic value of one Suzuken Co Ltd stock under the Base Case scenario is 14 934.53 JPY.

Is Suzuken Co Ltd stock undervalued or overvalued?

Compared to the current market price of 5 184 JPY, Suzuken Co Ltd is Undervalued by 65%.